Industry News
New Research Links NAD+ Depletion to Accelerated Cellular Aging — What the Data Says
Editorial Standards
Avera Refined Wellness holds its research journal content to a standard requiring specific research claims to reference published, peer-reviewed sources — not general assertions. We are in the process of auditing and updating existing journal content to consistently meet this standard.
A series of recent studies from leading longevity labs has strengthened the case that NAD+ decline is a driver — not just a marker — of cellular aging. Here's a breakdown of the current evidence.
NAD+ Depletion and Cellular Aging: What the Latest Research Says
For the past decade, NAD+ has been one of the most intensely studied molecules in longevity science. A cluster of studies published in 2024 and early 2025 has added significant weight to the hypothesis that NAD+ decline is a causal driver of cellular aging — not merely a correlate.
The Core Finding
NAD+ (nicotinamide adenine dinucleotide) is a cofactor essential for mitochondrial energy production and DNA repair. Levels decline by approximately 50% between the ages of 40 and 60 in most tissues.
Recent in-vitro work has shown that:
- Cells with artificially depleted NAD+ exhibit hallmarks of accelerated senescence within days
- Restoring NAD+ levels in aged cell cultures can partially reverse these phenotypes
- Sirtuins (NAD+-dependent deacetylases) show dramatically reduced activity in low-NAD+ environments, impairing their role in genome stability
Key Studies Worth Reviewing
Massudi H, Grant R, Braidy N, et al. (2012) — "Age-Associated Changes in Oxidative Stress and NAD+ Metabolism in Human Tissue," PLoS ONE 7(7):e42357. PMID: 22848760. PMCID: PMC3407129. This work documents that oxidative DNA damage drives PARP hyperactivation, which in turn depletes NAD+ in aging human tissue — the feedback loop accelerating cellular decline.
Sinclair Lab ongoing work — continues to build the case that NAD+ decline is upstream of many aging phenotypes, including telomere attrition and epigenetic drift.
Implications for Longevity Research
The mechanistic picture becoming clearer is: age-related oxidative stress → DNA damage → PARP activation → NAD+ depletion → impaired sirtuin activity → further genomic instability. Breaking this cycle at the NAD+ level is an active area of in-vitro investigation.
For researchers working in longevity biology, NAD+ remains one of the most tractable intervention points for in-vitro study of aging mechanisms.
All products sold by Avera Refined Wellness are for in-vitro laboratory research use only. Not for human consumption.
Research Disclaimer: All content published in the Avera Research Journal is provided for informational and scientific discussion purposes only. It does not constitute medical advice, treatment guidance, or a recommendation for human use of any compound. All Avera products are supplied exclusively for in-vitro laboratory research by qualified professionals. Not FDA-evaluated. Not for human consumption.
This article is for informational and research purposes only. All compounds referenced are sold strictly for in-vitro laboratory research use and are not intended for human consumption, veterinary use, or clinical/diagnostic procedures. These statements have not been evaluated by the FDA. Avera Refined Wellness is a subsidiary of RDS 412 LLC.
Related Research